FRESENIUS MEDICAL CARE AG & | 69.78 / +1.34% |
Date/Time | 01/26 / 17:29 |
Chg. / Chg.(%) | 0.92 / +1.34% |
Bid | 69.30 / 5 |
Ask | 82.88 / 251 |
Open | 68.46 |
Previous Close | 68.86 |
High | 69.80 |
Low | 68.44 |
Volume [EUR] | 7,351,932.43 |
Volume [Units] | 107,961 |
Price fixings | 2508 |
ISIN | DE0005785802 |
Security | FME/D |
Exchange | Turquoise |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 69.50 | ![]() |
484,128 |
Cboe Europe .. | 69.80 | ![]() |
194,755 |
London Inter.. | 69.53 | ![]() |
160,942 |
Turquoise | 69.78 | ![]() |
107,961 |
TradeGate | 69.740 | ![]() |
13,144 |
Stuttgart | 69.460 | ![]() |
2,344 |
Frankfurt | 69.5400 | ![]() |
1,231 |
gettex | 69.440 | ![]() |
744 |
Hamburg | 69.54 | ![]() |
227 |
München | 69.48 | ![]() |
60 |
Cboe Europe .. | 69.14 | ![]() |
50 |
Cboe Europe .. | 69.58 | ![]() |
3 |
Vienna Globa.. | 69.80 | ![]() |
0 |
Düsseldorf | 69.44 | ![]() |
0 |
Berlin | 69.52 | ![]() |
0 |
Hannover | 68.82 | ![]() |
0 |
Lang & Schwa.. | 69.420 | ![]() |
|
Borsa Italia.. | 69.22 | 55 | |
Nasdaq Other.. | 82.6200 | 1,000 | |
Mexico | 1,938.55 | ![]() |
760 |
EUREX | Options |
News
- ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
12/21/2020 / 22:05 - GlobeNewswire - Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
11/09/2020 / 07:00 - GlobeNewswire - ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
11/03/2020 / 14:30 - GlobeNewswire - Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis patients with pruritus
10/20/2020 / 07:00 - GlobeNewswire - ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
05/18/2020 / 14:30 - GlobeNewswire